At a glance
ClinicalIndex Comparison RecordN/ACompleted· 43 enrolled
Drug / intervention
JUUL +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Single-Center Clinical Trial to Evaluate Selected Constituents in the Exhaled Breath and Room Air From the Use of E-vapor Products and Conventional Cigarettes Studied Under Residential, Office and Hospitality Environmental Conditions
In Brief
A clinical study evaluating JUUL, VUSE Solo, and 1 other intervention for Second Hand Tobacco Smoke. Completed, enrolled 43 participants across 1 site.
Detailed Summary
An open-label, single center, three-arm observational study to examine emissions from e-cigarettes versus conventional cigarettes under three environmental settings of typical residential, office and hospitality facilities.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSecond Hand Tobacco Smoke
CountriesCanada
CollaboratorsInflamax Research Incorporated
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartSep 2018
Primary CompletionDec 2018
TodayJul 2026
First PostedJul 30, 2018
Enrollment StartSep 17, 2018
Primary CompletionDec 2, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.9 years ago
Interventions
JUULother
JUUL Virginia Tobacco
VUSE Soloother
VUSE SOLO Original
Conventional Cigaretteother
Subject preferred conventional cigarette